ÂÜÀòÂÒÂ×

Marianne Dicander Alexandersson serves as Chairman at Occlutech since April 2021, leading a company recognized globally for its innovations in structural heart disease. Additionally, Marianne holds board positions at Linc AB, Saminvest AB, and Sahlgrenska Science Park, contributing to the oversight of investments and the development of venture capital in the Life Science sector. Previous board roles include Membership at Praktikertjänst AB and Skandia, and board memberships at Enzymatica AB, Recipharm, and Camurus. In these roles, Marianne has been involved in various committees, including audit and remuneration committees, ensuring sound governance and strategic direction across organizations in healthcare and pharmaceuticals.